Clinical Trials Directory

Trials / Conditions / Kaposiform Hemangioendothelioma

Kaposiform Hemangioendothelioma

8 registered clinical trials studyying Kaposiform Hemangioendothelioma — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingSirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma
NCT07131644
West China HospitalPhase 2
UnknownPercutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies
NCT04921722
Children's Hospital of Fudan UniversityPhase 4
RecruitingThe Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma
NCT05351216
Children's Hospital of Fudan University—
CompletedEfficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelio
NCT04775173
West China HospitalPhase 2
CompletedGuided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangi
NCT04448873
Children's Hospital of Fudan UniversityPhase 4
CompletedSafety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
NCT04077515
Children's Hospital of Fudan UniversityPhase 4
CompletedSirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma
NCT03188068
West China HospitalPhase 2
RecruitingIdentification of Biomarkers for Patients with Vascular Anomalies
NCT03001180
Children's Hospital Medical Center, Cincinnati—